Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

VERV Verve Therapeutics Inc

5,19

0,05 (0,97%)

01 Jun 2024 - Geschlossen

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Verve Therapeutics (NASDAQ:VERV)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Verve Therapeutics Charts.

Verve Therapeutics (NASDAQ:VERV)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Verve Therapeutics Charts.

News Verve Therapeutics Inc

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Freitag 31 Mai 2024 (1 Tag vor) • GlobeNewswire Inc.

Form 8-K - Current report
Freitag 31 Mai 2024 (2 Tage vor) • Edgar (US Regulatory)

Verve Therapeutics Announces Leadership Update
Freitag 31 Mai 2024 (2 Tage vor) • GlobeNewswire Inc.

Verve Therapeutics to Participate in Upcoming Investor Conferences
Donnerstag 30 Mai 2024 (2 Tage vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 8 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 8 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results
Mittwoch 8 Mai 2024 (4 Wochen vor) • GlobeNewswire Inc.

Verve Therapeutics Announces Dosing of First Patient in Heart-2 Phase 1b Clinical Trial Evaluating VERVE-102
Dienstag 7 Mai 2024 (4 Wochen vor) • GlobeNewswire Inc.

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Freitag 3 Mai 2024 (4 Wochen vor) • GlobeNewswire Inc.

Verve Therapeutics Announces Updates on its PCSK9 Program
Dienstag 2 April 2024 (2 Monate vor) • GlobeNewswire Inc.

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Donnerstag 28 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Freitag 1 März 2024 (3 Monate vor) • GlobeNewswire Inc.

Weitere Verve Therapeutics Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen